Funding Received
$35.3 Million in 2 Rounds from 5 Investors
Most Recent Funding
$25.7 Million Series B on November 4, 2013
Headquarters:
Vienna
Description:
Hookipa Biotech develops prophylactic and therapeutic vaccines for the prevention and treatment of multiple infectious diseases and cancer.
Categories:
Biotechnology
Website:
http://hookipabiotech.com

Company Details

Update

Hookipa Biotech, a startup biotech company specialized in developing new generation vaccines. Founded in July 2011, in Austria, Hookipa Biotech has developed a proprietary technology platform, VaxwaveTM, dedicated to genetic vaccines for the prophylactic and therapeutic treatment of viral diseases. VaxwaveTM introduces a new approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity; the platform has been validated in different disease models. The company will use the Series A funds to advance its lead product HB101 through pre-clinical development and a Phase I proof of concept study, and to further industrialize and validate the VaxwaveTM technology.

Current Team (3)

Update

Past Team (1)

Update

Board Members and Advisors (1)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Helmut-Qualtinger-Gasse 2

    Vienna, 1030

    AUT

Images (1)

Update
  • Ecf1a032fc2500da8b14555ddfc548a4